» Articles » PMID: 23456297

Regulatory Effects of Resveratrol on Antioxidant Enzymes: a Mechanism of Growth Inhibition and Apoptosis Induction in Cancer Cells

Overview
Journal Mol Cells
Publisher Elsevier
Date 2013 Mar 5
PMID 23456297
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol (RSV) is a natural polyphenol that is known as a powerful chemopreventive and chemotherapeutic anticancer molecule. This study focused on the effects of RSV on the activities and expression levels of antioxidant enzymes in the cancer cells. Prostate cancer PC-3 cells, hepatic cancer HepG2 cells, breast cancer MCF-7 cells and the non-cancerous HEK293T kidney epithelial cells were treated with a wide range of RSV concentrations (10-100 μM) for 24-72 h. Cell growth was estimated by trypan blue staining, activities of the antioxidant enzymes were measured spectrophotometrically, expression levels of the antioxidant enzymes were quantified by digitalizing the protein band intensities on Western blots, and the percentage of apoptotic cells was determined by flow cytometry. Treatment with a low concentration of RSV (25 μM) significantly increased superoxide dismutase (SOD) activity in PC-3, HepG2 and MCF-7 cells, but not in HEK293T cells. Catalase (CAT) activity was increased in HepG2 cells, but no effect was found on glutathione peroxidase (GPX) upon RSV treatment. RSV-induced SOD2 expression was observed in cancer cells, although the expression of SOD1, CAT and GPX1 was unaffected. Apoptosis increased upon RSV treatment of cancer cells, especially in PC-3 and HepG2 cells. Together, our data demonstrated that RSV inhibits cancer cell growth with minimal effects on non-cancerous cells. We postulate that the disproportional up-regulation of SOD, CAT and GPX expression and enzymatic activity in cancer cells results in the mitochondrial accumulation of H2O2, which in turn induces cancer cell apoptosis.

Citing Articles

Resveratrol inhibited colorectal cancer progression by reducing oxidative DNA damage by targeting the JNK signaling pathway.

Maleki M, Tabnak P, Golchin A, Yousefi B, Nazari A Heliyon. 2024; 10(21):e38631.

PMID: 39524725 PMC: 11550663. DOI: 10.1016/j.heliyon.2024.e38631.


Dietary resveratrol improves immunity and antioxidant defense in ewes by regulating the rumen microbiome and metabolome across different reproductive stages.

Li X, Sha Y, Li S, Wang Z, Yang Y, Jiao T Front Immunol. 2024; 15:1462805.

PMID: 39464877 PMC: 11502325. DOI: 10.3389/fimmu.2024.1462805.


Targeting catalase in cancer.

Glorieux C, Buc Calderon P Redox Biol. 2024; 77:103404.

PMID: 39447253 PMC: 11539659. DOI: 10.1016/j.redox.2024.103404.


The protective role of resveratrol against high glucose-induced oxidative stress and apoptosis in HepG2 cells.

Tshivhase A, Matsha T, Raghubeer S Food Sci Nutr. 2024; 12(5):3574-3584.

PMID: 38726423 PMC: 11077230. DOI: 10.1002/fsn3.4027.


Relation between Strawberry Fruit Redness and Bioactivity: Deciphering the Role of Anthocyanins as Health Promoting Compounds.

Martinez-Ferri E, Forbes-Hernandez T, Cervantes L, Soria C, Battino M, Ariza M Foods. 2024; 13(1).

PMID: 38201141 PMC: 10778386. DOI: 10.3390/foods13010110.


References
1.
Huang X, Zhu H . Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med Chem. 2011; 11(5):479-90. DOI: 10.2174/187152011795677427. View

2.
Kasapovic J, Pejic S, Todorovic A, Stojiljkovic V, Pajovic S . Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct. 2008; 26(6):723-30. DOI: 10.1002/cbf.1499. View

3.
Petit E, Courtin A, Kloosterboer H, Rostene W, Forgez P, Gompel A . Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition. J Steroid Biochem Mol Biol. 2009; 115(3-5):153-60. DOI: 10.1016/j.jsbmb.2009.04.002. View

4.
Patel K, Scott E, Brown V, Gescher A, Steward W, Brown K . Clinical trials of resveratrol. Ann N Y Acad Sci. 2011; 1215:161-9. DOI: 10.1111/j.1749-6632.2010.05853.x. View

5.
Sharma A, Tripathi M, Satyam A, Kumar L . Study of antioxidant levels in patients with multiple myeloma. Leuk Lymphoma. 2009; 50(5):809-15. DOI: 10.1080/10428190902802323. View